Glaucoma Surgical Devices Market Scope
Glaucoma is an ophthalmic disease that affects the optic nerve of the iris and progression of the same results in blindness and vision loss. According to the World Health Organization (WHO), glaucoma is the most cause of blindness across the world. Presently, there are no existing treatments for glaucoma; however, some commercially available therapies focus on reducing the intraocular pressure, which is responsible for the development and progression of the disease. The treatment for glaucoma starts with topical eye drops, which is an alternative used to delay surgery. The increasing global burden of glaucoma is expected to contribute to market growth over the forecast period.
|Unit||Value (USD Million)|
|Key Companies Profiled||Essilor International (France), Alcon, Inc. (Switzerland), Johnson & Johnson (United States), Bausch + Lomb (United States), Glaukos Corporation (United States), New World Medical, Inc. (United States), Ellex Medical Lasers Ltd. (Australia), Haag-Streit (Switzerland), Topcon Corporation (Japan), Carl Zeiss Meditec (Germany), NIDEK (Japan) and STAAR Surgical (United States)|
Research Analyst at AMA estimates that European and United States Players will contribute to the maximum growth of Global Glaucoma Surgical Devices market throughout the predicted period.
Essilor International (France), Alcon, Inc. (Switzerland), Johnson & Johnson (United States), Bausch + Lomb (United States), Glaukos Corporation (United States), New World Medical, Inc. (United States), Ellex Medical Lasers Ltd. (Australia), Haag-Streit (Switzerland), Topcon Corporation (Japan), Carl Zeiss Meditec (Germany), NIDEK (Japan) and STAAR Surgical (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Lumenis Ltd. (Israel), Allergan Plc. (Ireland), Ziemer Ophthalmic Systems (Switzerland), HumanOptics AG (Germany), Sonomed Escalon (United States) and PhysIOL S.A. (Belgium).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
The study have segmented the market of Global Glaucoma Surgical Devices market by Type and Region with country level break-up.
On the basis of geography, the market of Glaucoma Surgical Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.
Market Leaders and their expansionary development strategies
On 21 st November 2019, Glaukos Corporation, an ophthalmic medical technology, and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases have announced that it has completed its previously announced acquisition of Avedro, Inc.
Glaucoma Surgical Devices Market Dynamics:
|Trends Influencing Market|
- Increase in Health Care Expenditure
- Less Awareness About the Glaucoma Surgery in Under Developed Countries
- Lack of Skilled Working Professionals
- Increase in Geriatric Population across the Globe
- Technological Advancement and Development in the Manufacturing of Glaucoma Surgical Devices
Key Target AudienceGlaucoma Surgical Devices Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others